Inhaled pharmacotherapy and stroke risk in patients with chronic obstructive pulmonary disease: A nationwide population based study using two-stage approach

Agriculture & Biology

• stroke 87%
• respiratory tract diseases 84%
• drug therapy 77%
• adrenal cortex hormones 44%
• agonists 18%
• antagonists 16%
• cohort studies 13%
• risk reduction 12%
• demography 10%
• calibration 9%
• therapeutics 7%
• incidence 6%
• methodology 2%

Medicine & Life Sciences

• Chronic Obstructive Pulmonary Disease 69%
• Stroke 53%
• 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole 51%
• Drug Therapy 45%
• Adrenal Cortex Hormones 31%
• Population 30%
• Muscarinic Antagonists 23%
• Risk Adjustment 12%
• Propensity Score 10%
• Calibration 10%
• Risk Reduction Behavior 9%
• Cohort Studies 6%
• Therapeutics 6%
• Demography 6%
• Incidence 4%

Chemical Compounds

• Adrenal Cortex Hormone 100%
• Muscarinic Antagonist 60%
• Disorder 16%
• Reduction 8%